Trials
Regulations
Contact Us

Welcome to pediculosis.com

Pediculosis.com is the world's only website aimed specifically at researchers, product managers and buyers in the head lice industry.

We provide regularly-updated information on new products, industry changes, regulatory issues, clinical trials and studies to help you identify emerging global trends and business opportunities.

btn-readmore

Industry News

      

Scientific News

newsimg-ind

newsimg-sci

18.03.15 | Head lice treatment company financial updates

Several head lice companies have recently released financial updates related to their head lice treatments.

18.03.15 | Tyratech increase Vamousse distribution and sales

Tyratech have announced increased sales for the Vamousse head lice treatment, and are extending their distribution network in both the US and the UK.

18.03.15 | New coat-stand to stop head lice spread in schools.

A new treated coat-stand is being trialled in France, aiming to reduce the spread of head-lice in schools.

30.01.15 | Pediculosis treatment product news Jan 2015

A summary of recent pediculosis product news.

24.12.14 | Trading updates for head lice products

Two companies producing market-leading head lice products have released recent trading updates.

18.03.15 | Novel pediculicide from bark extract

 

A new publication reports on testing of a Brazilian tree-bark extract for treating lice infection.

30.01.15 | Under-reported pediculosis papers in 2014

Like the subjects of their study, coverage of academic discussions of pediculosis treatment is often incomplete. Here are three such articles from 2014 which required a second round of treatment to get hold of:

Pediculosis in Evidence-Based Dermatology

The third edition of Evidence-Based Dermatology, edited by Williams, et al. and published by John Wiley & Sons in June 2014, contains a revised chapter by Burgess & Casey on the treatment of head lice.

The chapter is a general review of the etiology of head lice and contains broad coverage of the benefits of different forms of treatment.

Egg-hatching times measured

A paper by Burgess was published in the June 2014 edition of Medical and Veterinary Entomology, giving a high-level review of the data from twenty clinical trials on how long lice eggs take to hatch.

The review found that greater than 1% of lice eggs were found to hatch at thirteen days or more after first treatment (before which it was assumed that eggs had been killed). The study therefore recommends a revised treatment regime of three doses at weekly intervals, in order to better manage this small number of late-hatching eggs.

Reviewing popular discussion of pediculosis treatments

A paper by Hine published in the July 2014 edition of the Public Understanding of Science discusses the way in which members of the public deploy scientific knowledge in discussing optimal treatments for head lice.

Focussing on interactions in online forums, the author examines how parents justify their treatment choices based on the information they have available to them.

30.01.15 | Clinical Trials Update Jan 2015

 Recent news relevant to clinical trials on pediculosis.

29.09.14 | New Review of Lice Treatments

A new critical review of head lice treatments covers the latest treatment methods and clinical trial methodology.

04.09.14 | Successful Phase 3 results for Hatchtech Xeglyze trials

Hatchtech Pty Ltd this week announced successful results for its phase 3 trials of Xeglyze™ Lotion, a novel lice and egg treatment.

morenews-ind.png morenews-sci.png
  • Licecomb Engineering
  • Pediculosis.com: The world's only specialist website for the head lice industry
  • Scientific News
  • Company News
  • Regulatory News

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved